I agree that this site is using cookies. You can find further informations here.
X
Larkindale, J.
79  results:
Search for persons X
?
1

Correction: Developing a Natural History Model for Duchenne..:

Broomfield, Jonathan ; Hill, M. ; Chandler, F....
PharmacoEconomics - Open.  8 (2024)  4 - p. 643-643 , 2024
Link: https://doi.org/10.1007/..
 
?
2

P391 Phase 1 study to assess safety, tolerability, pharmaco..:

Shoskes, J. ; Larkindale, J. ; Cormier, J....
Neuromuscular Disorders.  33 (2023)  - p. S156 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P26 CONNECT-EDO51: Trial designs to support the development..:

Larkindale, J. ; Vacca, S. ; Cormier, J....
Neuromuscular Disorders.  33 (2023)  - p. S103 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Developing a Natural History Model for Duchenne Muscular Dy..:

Broomfield, Jonathan ; Hill, M. ; Chandler, F....
PharmacoEconomics - Open.  8 (2023)  1 - p. 79-89 , 2023
Link: https://doi.org/10.1007/..
 
?
5

P44 Phase 1 study of PGN-EDO51 demonstrates tolerability, d..:

Larkindale, J. ; Lonkar, P. ; Goyal, J....
Neuromuscular Disorders.  33 (2023)  - p. S69 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P.120 Unlocking the potential of oligonucleotide therapeuti..:

Mellion, M. ; McArthur, J. ; Holland, A....
Neuromuscular Disorders.  32 (2022)  - p. S99 , 2022
Link: https://doi.org/10.1016/..
 
?
7

DMD/BMD – OUTCOME MEASURES:

Broomfield, J. ; Hill, M. ; Guglieri, M....
Neuromuscular Disorders.  31 (2021)  - p. S85 , 2021
Link: https://doi.org/10.1016/..
 
?
8

DMD – BIOMARKERS & OUTCOME MEASURES:

Larkindale, J. ; Kim, S. ; LIngineni, K....
Neuromuscular Disorders.  30 (2020)  - p. S83 , 2020
Link: https://doi.org/10.1016/..
 
?
9

REGISTRIES, CARE, QUALITY OF LIFE, MANAGEMENT OF NMD:

Larkindale, J. ; Boulanger, V. ; Gavin, P....
Neuromuscular Disorders.  30 (2020)  - p. S146 , 2020
Link: https://doi.org/10.1016/..
 
?
10

MUSCLE IMAGING – MRI:

Vandenborne, K. ; Kim, S. ; Willcocks, R....
Neuromuscular Disorders.  30 (2020)  - p. S93-S94 , 2020
Link: https://doi.org/10.1016/..
 
?
11

EP.88Development of clinical trial simulation tool for Duch..:

Larkindale, J. ; Conrado, D. ; Corey, D..
Neuromuscular Disorders.  29 (2019)  - p. S178 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Friedreich's Ataxia-Health Index: Development and Validatio..:

Seabury, Jamison ; Rosero, Spencer ; Varma, Anika...
Neurology Clinical Practice.  13 (2023)  5 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
13

PGN-EDO51: Preclinical Data Supporting the Development of a..:

Holland, Ashling ; Godfrey, Caroline ; Lonkar, Pallavi...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
14

PGN-EDO51, an Enhanced Delivery Oligonucleotide (EDO) for t..:

Mellion, Michelle ; Larkindale, Jane ; Lonkar, Pallavi...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
15

Design of a Phase 1, Placebo-Controlled Study to Assess the..:

Mellion, Michelle ; Larkindale, Jane ; Cormier, Jennifer...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
1-15